Moderate hypofractionated radiotherapy after prostatectomy for cancer patients: toxicity and clinical outcome

References

• Global Burden of Disease Cancer Collaboration Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study JAMA Oncol 2016 3 4 524 548
   Web of Science ®Google Scholar
• BollaMvan PoppelHTombalB Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911) Lancet 2012 380 9858 2018 2027 23084481
   PubMed Web of Science ®Google Scholar
• ThompsonIMTangenCMParadeloJ Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial J Urol 2009 181 3 956 962 19167731
   PubMed Web of Science ®Google Scholar
• WiegelTBartkowiakDBottkeD Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 Trial Eur Urol 2014 66 2 243 250 24680359
   PubMed Web of Science ®Google Scholar
• BrennerDJ Hypofractionation for prostate cancer radiotherapy – what are the issues? Int J Radiat Oncol Biol Phys 2003 57 4 912 914 14575821
   PubMed Web of Science ®Google Scholar
• CozzariniCFiorinoCDi MuzioN Hypofractionated adjuvant radiotherapy with helical Tomotherapy after radical prostatectomy: Planning data and toxicity results of a Phase I-II study Radiother Oncol 2008 88 1 26 33 18455253
   PubMed Web of Science ®Google Scholar
• FowlerJF The radiobiology of prostate cancer including new aspects of fractionated radiotherapy Acta Oncol 2005 44 3 265 276 16076699
   PubMed Web of Science ®Google Scholar
• KatayamaSStrieckerTKesselK Hypofractionated IMRT of the prostate bed after radical prostatectomy: acute toxicity in the PRIAMOS-1 trial Int J Radiat Oncol Biol Phys 2014 90 4 926 933 25216858
   PubMed Web of Science ®Google Scholar
• HaustermansKMGHoflandIVan PoppelH Cell kinetic measurements in prostate cancer Int J Radiat Oncol Biol Phys 1997 37 5 1067 1070 9169814
   PubMed Web of Science ®Google Scholar
• KhooVSPollackACowenD Relationship of Ki-67 labeling index to DNA-ploidy, S-phase fraction, and outcome in prostate cancer treated with radiotherapy Prostate 1999 41 3 166 172 10517874
   PubMed Web of Science ®Google Scholar
• AlongiFFiorinoCCozzariniC IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with postoperative adjuvant or salvage radiotherapy after radical prostatectomy Radiother Oncol 2009 93 2 207 212 19766338
   PubMed Web of Science ®Google Scholar
• CozzariniCFiorinoCDeantoniC Higher-than-expected severe (Grade 3–4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients Eur Urol 2014 66 6 1024 1030 24985964
   PubMed Web of Science ®Google Scholar
• BriaECupponeFGiannarelliD Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer? Cancer 2009 115 15 3446 3456 19484790
   PubMed Web of Science ®Google Scholar
• D’AmicoAVMoulJCarrollPRSunLLubeckDChenMH Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era J Clin Oncol 2003 21 11 2163 2172 12775742
   PubMed Web of Science ®Google Scholar
• SasseADSasseECarvalhoAMMacedoLT Androgenic suppression combined with radiotherapy for the treatment of prostate adenocarcinoma: a systematic review BMC Cancer 2012 12 1 54 22299707
   PubMedGoogle Scholar
• DonovanJLHamdyFCLaneJA Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer N Engl J Med 2016 375 15 1425 1437 27626365
   PubMed Web of Science ®Google Scholar
• RoachM3rdMarquezCYuoHS Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and gleason score in men with clinically localized prostate cancer Int J Radiat Oncol Biol Phys 1994 28 1 33 37 7505775
   PubMed Web of Science ®Google Scholar
• MichalskiJMLawtonCEl NaqaI Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer Int J Radiat Oncol Biol Phys 2010 76 2 361 368 19394158
   PubMed Web of Science ®Google Scholar
• GladwishALoblawACheungP Accelerated hypofractioned postoperative radiotherapy for prostate cancer: a prospective phase I/II study Clin Oncol 2015 27 3 145 152
   Web of Science ®Google Scholar
• TyldesleySPeacockMMorrisJW The need for, and utilization of prostate-bed radiotherapy after radical prostatectomy for patients with prostate cancer in British Columbia Can Urol Assoc J 2012 6 2 89 94 22511413
   PubMed Web of Science ®Google Scholar
• CozzariniCMontorsiFFiorinoC Need for high radiation dose (>or= 70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients Int J Radiat Oncol Biol Phys 2009 75 4 966 974 19619960
   PubMed Web of Science ®Google Scholar
• KingCR The timing of salvage radiotherapy after radical prostatectomy: a systematic review Int J Radiat Oncol Biol Phys 2012 84 1 104 111 22795730
   PubMed Web of Science ®Google Scholar
• OhriNDickerAPTrabulsiEJShowalterTN Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling Eur J Cancer 2012 48 6 837 844 21945099
   PubMed Web of Science ®Google Scholar
• GhadjarPHayozSBernhardJr Acute toxicity and quality of life after dose-intensified salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: first results of the randomized trial SAKK 09/10 J Clin Oncol 2015 33 35 4158 4166 26527774
   PubMed Web of Science ®Google Scholar
• CozzariniCFiorinoCDa PozzoLF Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: a single-institute analysis of 742 patients Int J Radiat Oncol Biol Phys 2012 82 1 191 199 21109361
   PubMed Web of Science ®Google Scholar
• FersinoSTebanoUMazzolaR Moderate hypofractionated postprostatectomy volumetric modulated arc therapy with daily image guidance (VMAT-IGRT): a mono-institutional report on feasibility and acute toxicity Clin Genitourin Cancer 2017 15 4 e667 e673 28237181
   PubMed Web of Science ®Google Scholar
• KruserTJJarrardDFGrafAK Early hypofractionated salvage radiotherapy for post-prostatectomy biochemical recurrence Cancer 2011 117 12 2629 2636 21656740
   PubMed Web of Science ®Google Scholar
• MassaccesiMCillaSDeodatoF Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial Anticancer Res 2013 33 6 2785 2789 23749942
   PubMed Web of Science ®Google Scholar
• AzelieCGauthierMLMirjoletCL Exclusive image guided IMRT vs. radical prostatectomy followed by postoperative IMRT for localized prostate cancer: a matched-pair analysis based on risk-groups Radiat Oncol 2012 7 1 158 22978763
   PubMedGoogle Scholar
• GoenkaAMagsanocJMPeiX Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy Eur Urol 2011 60 6 1142 1148 21855208
   PubMed Web of Science ®Google Scholar
• BollaMVan TienhovenGWardeP External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study Lancet Oncol 2010 11 11 1066 1073 20933466
   PubMed Web of Science ®Google Scholar
• HorwitzEMBaeKHanksGE Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer J Clin Oncol 2008 26 15 2497 2504 18413638
   PubMed Web of Science ®Google Scholar
• PisanskyTMHuntDGomellaLG Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910 J Clin Oncol 2015 33 4 332 339 25534388
   PubMed Web of Science ®Google Scholar
• ZilliTDal PraAKountouriMMiralbellR Prognostic value of biochemical response to neoadjuvant androgen deprivation before external beam radiotherapy for prostate cancer: a systematic review of the literature Cancer Treat Rev 2016 46 35 41 27082769
   PubMed Web of Science ®Google Scholar